基础医学与临床 ›› 2007, Vol. 27 ›› Issue (1): 76-80.

• 研究论文 • 上一篇    下一篇

蛋白激酶C及磷脂酰肌醇3激酶参与心衷患者心肌重构的机制

杨永健 朱文玲 张鑫 孙梅芹   

  • 收稿日期:2006-01-16 修回日期:2006-04-29 出版日期:2007-01-25 发布日期:2007-01-25
  • 通讯作者: 杨永健

Protein kinase C and phosphatidyliositol 3 kinase involved in the mechanism of myocardial remodeling in patients with congestive heart failure

  

  • Received:2006-01-16 Revised:2006-04-29 Online:2007-01-25 Published:2007-01-25

摘要: 目的 探讨蛋白激酶C(PKC)/丝裂原活化蛋白激酶(MAPK)、磷脂酰肌醇3激酶(PI3K)/ 蛋白激酶B(Akt)信号通路参与心力衰竭(CHF)患者心肌重塑的机制。方法 选择因瓣膜性心脏病接受二尖瓣置换术的CHF患者39例,正常对照38例(其中8例来自意外伤亡的器官捐献者)。彩色多普勒超声心动仪检测心脏扩大和心功能参数,放射免疫法检测血浆及心肌组织中AngII浓度,竞争蛋白结合法检测PKC,免疫沉淀法检测MAPK活性,免疫沉淀法测心肌组织PI3K/Akt磷酸化、c-fos、α-骨骼肌动蛋白(α-skeletal-actin)的表达。结果 CHF患者心肌组织呈典型重构心肌的病理改变。血浆及心肌组织AngⅡ浓度与心功能级别呈正相关。CHF患者心肌组织PKC和MAPK活性明显高于对照组(P <0.01),并随心功能恶化其表达逐渐增加; CHFⅡ级组患者心肌组织PI3K/Akt磷酸化明显强于正常对照组(P<0.01)和CHFⅢ、Ⅳ级组(P<0.01)。 CHFⅢ、Ⅳ级组间没有差异。 正常心肌组织中无c-fos蛋白表达,CHFⅡ级组c-fos蛋白表达明显高于Ⅲ、Ⅳ级组(P<0.01)。 CHF患者心肌组织α-skeletal-actin表达明显高于对照组(P<0.01),并随心功能恶化其表达逐渐增加。结论 PKC/MAPK及PI3K/Akt信号通路共同参与调节CHF患者心肌重构的病理过程。

Abstract: Objective To investigate the involvement of mitogen-activated protein kinase(MAPK)and PI3K(phosphatidylinositol 3 kinase)/ Protein kinase B (Akt) signal transduction pathways in the mechanism of myocardium remodeling in patients with congestive heart failure(CHF) Methods Thirty nine patients of mitral valve disease with CHF were randomly selected and 30 cases of healthy persons were included as controls. Cardiac function parameters were measured by echocardiography. Concentrations of AngⅡ in plasma and myocardial tissues were determined by radio immunoassay. Activity of PKC was determined by using competive prote in binding method, activity of MAPK was detected by the methods of immunoprecitipation. Immunoprecitipation was used to assay the protein expression and phosphorylation of PI3K and Akt(Protein kinase B), protein expression of c-fos and α-skeletal-actin in myocardial tissues. Results Pathological changes of myocardial tissues in CHF with valvular heart disease showed typical myocardial remodeling. The hypertrophy was dominant at early stagy of CHF, while at end stage the characteristics include disordered alignament of the myocytes, the discontinuity and dissolving of cardiomyofibrills, destroyed subcellular organs, and the hyperplasia of interstitial tissue. AngⅡconcentrations in plasm and myocardial tissues in patients with CHF were higher than those in the control group(P<0.01), their levels were positively correlated to the levels of CHF; the activities of PKC and MAPK in myocardial tissues in patients with CHF were higher than those in control group(P<0.01), their levels were positively correlated to the levels of CHF (P<0.01). Compared to control group, phosphorylation of PI3K , Akt were higer in heart function class Ⅱgroup than that of heart function classⅢ and heart function class Ⅳgroups(P<0.01),there were no difference between heart function class Ⅲand Ⅳgroups; protein expression of c-fos was obvious in heart function Ⅱgroup (P<0.01) , but it is higer in heart function class Ⅲ and Ⅳ groups compared with heart function Ⅱgroup(P<0.01). The protein expression of α-skeletal-actin also increased in myocardial tissues in CHF groups, but positively correlated to cardiac function, there were big differences from control group(P<0.01). Conclusion Both PKC/MAPK and PI3K/Akt signal pathways involve in the pathogenesis of myocardial remodeling in CHF patients with valvular heart disease